Browsing Centre for Genomics and Child Health by Author "Lugemwa, A"
Now showing items 1-3 of 3
-
Effect of ready-to-use supplementary food on mortality in severely immunocompromised HIV-infected individuals in Africa initiating antiretroviral therapy (REALITY): an open-label, parallel-group, randomised controlled trial.
Mallewa, J; Szubert, AJ; Mugyenyi, P; Chidziva, E; Thomason, MJ; Chepkorir, P; Abongomera, G; Baleeta, K; Etyang, A; Warambwa, C (Elsevier/Science Direct, 2018-04-10)BACKGROUND: In sub-Saharan Africa, severely immunocompromised HIV-infected individuals have a high risk of mortality during the first few months after starting antiretroviral therapy (ART). We hypothesise that universally ... -
Enhanced infection prophylaxis reduces mortality in severely immunosuppressed HIV-infected adults and older children initiating antiretroviral therapy in Kenya, Malawi, Uganda and Zimbabwe: the REALITY trial
Hakim, J; Musiime, V; Szubert, AJ; Siika, A; Mallewa, J; Agutu, C; Pett, SL; Bwakura-Dangarembizi, M; Lugemwa, A; Kaunda, S (Wiley on behalf of International AIDS Society, 2016-07-22)Meeting abstract FRAB0101LB from 21st International AIDS Conference 18–22 July 2016, Durban, South Africa. Introduction: Mortality from infections is high in the first 6 months of antiretroviral therapy (ART) among ... -
Enhanced Prophylaxis plus Antiretroviral Therapy for Advanced HIV Infection in Africa
Hakim, J; Musiime, V; Szubert, AJ; Mallewa, J; Siika, A; Agutu, C; Walker, S; Pett, SL; Bwakura-Dangarembizi, M; Lugemwa, A (2017-07-20)